Table 5. . Follow-up amantadine test in the outlier group at Dhaka (Bangladesh site).

Subject ID	Initial			Follow-up 1			Follow-up 2
	2 h [AA] (ng/ml)	4 h [AA] (ng/ml)	6 h [AA] (ng/ml)	2 h [AA] (ng/ml)	4 h [AA] (ng/ml)	6 h [AA] (ng/ml)	2 h [AA] (ng/ml)	4 h [AA] (ng/ml)	6 h [AA] (ng/ml)
H03	11.9	165	156	21.0	30.3	41.4	11.4	113	30.9
H07	11.0	29.1	66.4	28.4	60.2	64.7	1.7	33.4	19.5
H11	3.0	185	45.1	7.1	36.3	77.2	1.5	45.2	67.3
H12	31.4	132	91.3	92.6	81.5	46.5	46.1	120	54.9
H17	9.8	60.8	27.3	39.4	71.2	42.3	6.7	25.0	48.3
H18	22.8	28.2	25.1	17.5	74.9	103	5.9	19.7	9.3
H26	14.9	24.0	8.0	6.8	46.9	21.5	1.8	14.3	26.4

Urinary AA concentrations were determined at 2, 4 and 6 h postamantadine ingestion at first follow-up (6 month) and at second follow-up (9-month) after the initial amantadine test.

AA: Acetylamantadine.